Pluri (PLUR) Total Debt (2021 - 2025)
Pluri (PLUR) posted quarterly Total Debt of $27.8 million for Q4 2025, up 16.74% year-over-year from $23.8 million in Q4 2024, and up 0.88% quarter-over-quarter from $27.5 million in Q3 2025.
Pluri (PLUR) Total Debt (2021 - 2025) Analysis & Trends
Pluri (PLUR) has reported Total Debt for 5 consecutive years, with $27.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Debt rose 16.74% year-over-year to $27.8 million; the TTM figure through Dec 2025 stood at $27.8 million (up 16.74% YoY), while the FY2025 annual figure was $27.3 million, up 13.58% from the prior year.
- Total Debt advanced to $27.8 million in Q4 2025 per PLUR's latest filing, from $27.5 million in the prior quarter.
- Across five years, Total Debt topped out at $27.8 million in Q4 2025 and bottomed at $20.7 million in Q3 2022.
- Historically, Total Debt has averaged $24.1 million across 5 years, with a median of $23.8 million in 2024.
- Annual changes were most pronounced in 2022 — Total Debt declined 11.61% — and 2025, when it rose 16.74%.
- Pluri's Total Debt stood at $23.2 million in 2021, then dropped by 2.09% to $22.7 million in 2022, then climbed by 7.61% to $24.4 million in 2023, then fell by 2.47% to $23.8 million in 2024, then grew by 16.74% to $27.8 million in 2025.
- Business Quant data shows PLUR's Total Debt at $27.8 million in Q4 2025, $27.5 million in Q3 2025, and $27.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | Pluri | 16.11 Mn | 3.63 Mn | 86,000.00 | 27.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.78 Mn |
| Sep 30, 2025 | 27.54 Mn |
| Jun 30, 2025 | 27.29 Mn |
| Mar 31, 2025 | 24.95 Mn |
| Dec 31, 2024 | 23.80 Mn |
| Sep 30, 2024 | 25.37 Mn |
| Jun 30, 2024 | 24.03 Mn |
| Mar 31, 2024 | 24.07 Mn |
| Dec 31, 2023 | 24.40 Mn |
| Sep 30, 2023 | 23.17 Mn |
| Jun 30, 2023 | 23.53 Mn |
| Mar 31, 2023 | 23.35 Mn |
| Dec 31, 2022 | 22.68 Mn |
| Sep 30, 2022 | 20.72 Mn |
| Jun 30, 2022 | 21.68 Mn |
| Mar 31, 2022 | 22.92 Mn |
| Dec 31, 2021 | 23.16 Mn |
| Sep 30, 2021 | 23.44 Mn |
| Jun 30, 2021 | 23.85 Mn |